The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction

被引:18
|
作者
Ohbayashi, Norihiko [1 ]
Kawakami, Shiho [1 ]
Muromoto, Ryuta [1 ]
Togi, Sumihito [1 ]
Ikeda, Osamu [1 ]
Kamitani, Shinya [1 ]
Sekine, Yuichi [1 ]
Honjoh, Tsutomu [2 ]
Matsuda, Tadashi [1 ]
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Morinaga Inst Biol Sci Inc, Yokohama, Kanagawa 2360003, Japan
关键词
IL-6; LIF; SENP1; SUMO; STAT3; PML; transcriptional regulation;
D O I
10.1016/j.bbrc.2008.04.179
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Post-translational modification by small ubiquitin-like modifier (SUMO) plays an important role in the regulation of different signaling pathways and is involved in the formation of promyelocytic leukemia (PML) Protein nuclear bodies following sumoylation of PML. In the present study, we found that IL-6 induces desumoylation of PML and dissociation between PML and SUMO1 in hepatoma cells. We also found that IL-6 induces mRNA expression of SENP1, a member of the SUMO-specific protease family. Furthermore, wild-type SENP1 but not an inactive SENP1 mutant restored the PML-mediated suppression of STAT3 activation. These results indicate that the IL-6 family of cytokines modulates STAT3 activation by desumoylation and inactivation PML through SENP1 induction. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:823 / 828
页数:6
相关论文
共 50 条
  • [31] Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
    Chen, Xiao-Wu
    Zhou, Shu-Feng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2941 - 2946
  • [32] A role of IL-1 and p38 MAPK in inhibition of IL-6 mediated Stat3 activation
    Ahmed, ST
    Ivashkiy, LB
    FASEB JOURNAL, 1999, 13 (05): : A1148 - A1148
  • [33] Gankyrin Promotes Tumor Growth and Metastasis Through Activation of IL-6/STAT3 Signaling in Human Cholangiocarcinoma
    Zheng, Tongsen
    Hong, Xuehui
    Wang, Jiabei
    Pei, Tiemin
    Liang, Yingjian
    Yin, Dalong
    Song, Ruipeng
    Song, Xuan
    Lu, Zhaoyang
    Qi, Shuyi
    Liu, Jiaren
    Sun, Boshi
    Xie, Changming
    Pan, Shangha
    Li, Yuejin
    Luo, Xiaohe
    Li, Shuai
    Fang, Xiang
    Bhatta, Nishant
    Jiang, Hongchi
    Liu, Lianxin
    HEPATOLOGY, 2014, 59 (03) : 935 - 946
  • [34] IL-6 Inhibition Reduces STAT3 Activation and Enhances the Antitumor Effect of Carboplatin
    Wang, Zhi-Yong
    Zhang, Jun-Ai
    Wu, Xian-Jin
    Liang, Yan-Fang
    Lu, Yuan-Bin
    Gao, Yu-Chi
    Dai, You-Chao
    Yu, Shi-Yan
    Jia, Yan
    Fu, Xiao-Xia
    Rao, Xiaoquan
    Xu, Jun-Fa
    Zhong, Jixin
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [35] Bit1 Silencing Enhances the Proliferation, Migration, and Invasion of Glioma Cells Through Activation of the IL-6/STAT3 Pathway
    Wang, Zhengfeng
    Yin, Menglei
    Wang, Ruihua
    Liu, Xianzhi
    Yan, Dongming
    ONCOTARGETS AND THERAPY, 2020, 13 : 2469 - 2481
  • [36] TFF1 SUPPRESSES IL-6 MEDIATED STAT3 ACTIVATION THROUGH INTERFERING WITH IL6Rα/GP130 COMPLEX FORMATION
    Soutto, Mohammed
    Chen, Zheng
    Bhat, Ajaz
    Bishop, Lihong
    Zhu, Shoumin
    Peng, Dunfa
    Gomaa, Ahmed R.
    Bates, Andreia
    Belkhiri, Abbes
    Piazuelo, M. Blanca
    Peek, Richard M.
    Washington, Kay
    El-Rifai, Wael M.
    GASTROENTEROLOGY, 2018, 154 (06) : S22 - S22
  • [37] Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells
    Chung, Seyung S.
    Wu, Yong
    Okobi, Quincy
    Adekoya, Debbie
    Atefi, Mohammad
    Clarke, Orette
    Dutta, Pranabananda
    Vadgama, Jaydutt V.
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [38] Small Molecule Inhibitors of IL-6/STAT3 Signaling
    Ye Jiqing
    Yue Xiaohong
    Sun Liping
    PROGRESS IN CHEMISTRY, 2016, 28 (07) : 1099 - 1111
  • [39] Inflammation and Cancer: IL-6 and STAT3 Complete the Link
    Bromberg, Jacqueline
    Wang, Timothy C.
    CANCER CELL, 2009, 15 (02) : 79 - 80
  • [40] Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially cytokine signaling 3
    Niemand, C
    Nimmesgern, A
    Haan, S
    Fischer, P
    Schaper, F
    Rossaint, R
    Heinrich, PC
    Müller-Newen, G
    JOURNAL OF IMMUNOLOGY, 2003, 170 (06): : 3263 - 3272